A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Thomas Jefferson University
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
Thomas Jefferson University
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Seagen Inc.
City of Hope Medical Center
Affimed GmbH
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Seagen Inc.
University of Virginia
ADC Therapeutics S.A.
Memorial Sloan Kettering Cancer Center
Jiangsu HengRui Medicine Co., Ltd.
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
Stanford University
SCRI Development Innovations, LLC
Bristol-Myers Squibb
Washington University School of Medicine
University of Nebraska
University of Nebraska
Vanderbilt-Ingram Cancer Center
Seagen Inc.
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research